Glenmark Pharmaceuticals Ltd Share Price – In terms of the Glenmark share price aim, we foresee a jump in Glenmark shares in the near future. The Glenmark business has thrived wonderfully and given investors with outstanding returns. Glenmark Company stockholders have profited handsomely. Investing makes sense. Glenmark Company will provide investors with substantial long-term profits.
About the Company- GLENMARK
Indian pharmaceutical business Glenmark Pharmaceuticals Ltd. is traded on both the Bombay Stock Exchange and the National Stock Exchange. The company was founded in 1977 and produces and supplies biosimilars, active pharmaceutical ingredients (APIs), and branded and generic formulations. Its 18 manufacturing sites in India, 7 in the United States, 1 in Brazil, and 1 in Mexico are spread throughout the globe to meet demand from all over the world. Glenmark has made a number of moves to establish a strong foothold in international markets.
Glenmark’s aggressive acquisition strategy and product launch activities, in addition to its product portfolio, have contributed to its increased market reach. The business has received many honors throughout the years, including being listed among the top 1000 pharmaceutical businesses in the world for several years running.
Overview of Glenmark Pharmaceuticals Ltd Share Price
| Mrket Cap | 44.16KCr |
| Listing At | NSE and BSE |
| 52 Week High | 1,576.00 |
| 52 Week Low | 722.00 |
| P/E Ratio (TTM) | -39.89 |
| P/B Ratio | 3.04 |
| Face Value | 1 |
| Dividend Yield | 0.25% |
Glenmark Pharmaceuticals Ltd Share Price Target 2024 To 2030
In 2023, the majority of Indian equities, including GLENMARK, saw an amazing bull run. The market’s optimistic outlook is expected to persist in the first quarter of 2024, despite the first months of consolidation. Technical analysis indicates that GLENMARK’s minimum share price target for 2024 is anticipated to be ₹1594.16, while the highest price target is anticipated to be ₹2256.58.
| Year | Share Price Target |
| 2024 | ₹1694 |
| 2025 | ₹1702 |
| 2026 | ₹1836 |
| 2027 | ₹1918 |
| 2028 | ₹2053 |
| 2029 | ₹2149 |
| 2030 | ₹2220 |
How to Buy Glenmark Pharma Ltd. Share
Glenmark Pharma Ltd. is listed on both the NSE and BSE. There are numerous brokers registered with SEBI to buy shares. Shares in any corporation can be easily purchased and sold through these brokers. Some popular brokers include – Zerodha Grow Angel One Upstox
Peer Companies For Glenmark Pharma Ltd. Share
Glenmark Pharma Ltd. competes with various outstanding corporations within the pharmaceutical industry, which include:
- Glenmark Pharmaceuticals Ltd
- Sun Pharmaceuticals
- Cipla Ltd
- Divis Laboratories
- Zydus lifesciences
It is important to remember that, while these price estimates are based on technical analysis, other market factors and news could have an impact on the stock’s performance. As a result, these hypothetical aims should serve as guides rather than financial advice. Always conduct your own due diligence before making any investment.
FAQs More About Glenmark Pharmaceuticals Ltd Share Price
Is Glenmark Pharmaceuticals Ltd listed on NSE?
Yes, Glenmark Pharmaceuticals Ltd is listed on NSE
Is it good to invest in Glenmark?
Glenmark Pharmaceuticals Ltd. Share has a “Buy” rating based on long-term analyst recommendations.
